Is serum ECP level helpful in determining discontinuation of inhaled corticosteroid therapy in asthmatic children?

Allergologia et Immunopathologia

Volumn 28, Issue 5, 2000, Pages 278-282

  Bahceciler, Nerin N ^a,b   Basdemir, D ^a   Nursoy, A M ^a   Nuhoglu Y ^a   Barlan, I B ^a   Basaran, M M ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Vefa Bey Sok   (Turkey)

Author keywords

Asthma; Children; Eosinophilic cationic protein; Inhaled corticosteroid; Therapy monitorization

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN;

ADOLESCENT; ARTICLE; ASTHMA; BLOOD LEVEL; CHILD; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE MARKER; DRUG MONITORING; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS; REMISSION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BIOLOGICAL MARKERS; BLOOD PROTEINS; BUDESONIDE; CHILD; CHILD, PRESCHOOL; EOSINOPHIL GRANULE PROTEINS; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT; MALE; RIBONUCLEASES;

EID: 0034503286     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Haley KJ, Drazen JM. Inflammation and airway function in asthma. Am J Respir Crit Care Med 1998;157:1-3.
2. Cockroft DW. Nonallergic airway responsiveness. J Allergy Clin Immunol 1998;81(1):111-19.
3. Moqbel R. Eosinophil derived cytokines in allergic inflammation and asthma. Ann NY Acad Sci 1996;209:209-17.
4. Martin LB, Kita H, Leiferman KM, et al. Eosinophils in allergy: Role in disease, degranulation and cytokines. Int Arch Allergy Immunol 1996;109:207-15.
5. Zimmerman B, Lanner A, Enander I, et al. Total blood eosinophils, serum eosinophilic cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 1993;23:564-70.
6. Wever AMJ, Wever-Hess J, Hermans J. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma. Clin Exp Allergy 1997;27: 519-29.
7. Sugai T, Sakiyama Y, Matumoto S. Eosinophil cationic protein in peripheral blood of paediatric patients with allergic ciseases. Clin Exp Allergy 1993;23:564-70.
8. Koller DY, Herouy Y, Götz M, Hagel E, Urbanek R, Eichler I. Clinical value of monitoring eosinophil activity in asthma. Arch Dis Child 1995;73:413-17.
9. Taylor IK, Shaw RJ. The mechanism of action of corticosteroids in asthma. Respir Med 1993;87:261-77.
10. Drazen JM, Israel E. Treating mild asthma-when are inhaled steroids indicated? N Engl J Med 1994;331:737-9.
11. Dukes MNG, Holgate ST, Pauwels RA. Report of an international workshop on risk and safety of asthma therapy. Clin Exp Allergy 1994;24:160-5.
12. American Thoracic Society, Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:25-44.
13. Wever AMJ, Wever H, Hensgens HESJ, Hermans J. Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PC20 and exacerbations. Respir Med 1994;88:613-21.
14. Carlsen KH, Halvorsen R, Pettersen M, Lodrup Carlsen KC. Inflammation markers and symptom activity in children with bronchial asthma. Influence of atopy and eczema. Pediatr Allergy Immunol 1997;8:112-20.
15. Zimmerman B, Enander I, Zimmerman R, Ahlstedt S. Asthma in children less than 5 years of age: eosinophils and serum levels of the eosinophil proteins ECP and EPX in relation to atopy and symptoms. Clin Exp Allergy 1994;24:149-55.
16. Iikura Y, Matsumoto T, Yoshida H, et al. Evaluation of serum eosinophil cationic protein (ECP) monitoring childhood asthma: ECP as a marker for indication and discontinuation of inhaled steroid therapy. J Allergy Clin Immunol 1993;101(1): S8 (Abstract).